Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M. Masuda N, et al. Among authors: lee sj, lee es. N Engl J Med. 2017 Jun 1;376(22):2147-2159. doi: 10.1056/NEJMoa1612645. N Engl J Med. 2017. PMID: 28564564 Free article. Clinical Trial.
Clinical study on death in Behçet's disease.
Park KD, Bang D, Lee ES, Lee SH, Lee S. Park KD, et al. Among authors: lee sh, lee es, lee s. J Korean Med Sci. 1993 Aug;8(4):241-5. doi: 10.3346/jkms.1993.8.4.241. J Korean Med Sci. 1993. PMID: 8198759 Free PMC article. Review.
Epidermolysis bullosa acquisita localized to the face.
Choi GS, Lee ES, Kim SC, Lee S. Choi GS, et al. Among authors: lee es, lee s. J Dermatol. 1998 Jan;25(1):19-22. doi: 10.1111/j.1346-8138.1998.tb02339.x. J Dermatol. 1998. PMID: 9519604 Review.
Three cases of cutaneous sparganosis.
Kim SH, Park K, Lee ES. Kim SH, et al. Among authors: lee es. Int J Dermatol. 2001 Oct;40(10):656-8. doi: 10.1046/j.1365-4362.2001.01287-5.x. Int J Dermatol. 2001. PMID: 11737430 No abstract available.
A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer.
Lee KS, Ro J, Nam BH, Lee ES, Kwon Y, Kwon HS, Chung KW, Kang HS, Kim EA, Kim SW, Shin KH, Kim SK. Lee KS, et al. Among authors: lee es. Breast Cancer Res Treat. 2008 Jun;109(3):481-9. doi: 10.1007/s10549-007-9672-y. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653851 Clinical Trial.
2,629 results